Results 41 to 50 of about 735,101 (274)

Efficacy and Safety of Programmed Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC: A Prospective Observational Study

JTO Clinical and Research Reports, 2022
Introduction: To date, the efficacy and safety of programmed death-ligand 1 (PD-L1) inhibitor plus platinum-etoposide chemotherapy for patients with extensive-stage SCLC (ES-SCLC), with real-world evidence, stratified on the basis of age and performance ...
Kenji Morimoto, MD, PhD, Tadaaki Yamada, MD, PhD, Takayuki Takeda, MD, PhD, Shinsuke Shiotsu, MD, Koji Date, MD, Taishi Harada, MD, Nobuyo Tamiya, MD, PhD, Yusuke Chihara, MD, PhD, Osamu Hiranuma, MD, Takahiro Yamada, MD, PhD, Hibiki Kanda, MD, Takayuki Nakano, PhD, Yoshie Morimoto, MD, PhD, Masahiro Iwasaku, MD, PhD, Shinsaku Tokuda, MD, PhD, Koichi Takayama, MD, PhD   +15 more
doaj   +1 more source

Depression, anxiety and their associated factors among patients with cancer receiving treatment at oncology units in Amhara Region, Ethiopia: a cross-sectional study

BMJ Open, 2022
Objective To assess the prevalence of anxiety and depression symptoms, and their associated factors among patients with cancer receiving cancer treatment in Amhara region oncology centres in Northwest, Ethiopia.Design Institution-based cross-sectional ...
Destaw Endeshaw, Tarkie Abebe Walle, Senay Yohannes   +2 more
doaj   +1 more source

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis. [PDF]

Transl Lung Cancer Res, 2021
Background: Immune checkpoint inhibitors (ICIs) have become the standard of care for the first-line treatment of advanced non-small cell lung cancer patients (NSCLC), either as single agents or combined with chemotherapy.
Facchinetti F, Di Maio M, Perrone F, Tiseo M.   +3 more
europepmc   +3 more sources

Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation [PDF]

Journal of Clinical and Experimental Hepatology, 2020
Performance status may adversely affect living donor liver transplantation (LDLT) outcomes. We present our data regarding performance status and posttransplantation survival in a large LDLT cohort.Patients with ABO incompatibility, of pediatric age, with acute liver failure, with hepatocellular carcinoma, and/or who had incomplete data were excluded ...
Narendra S. Choudhary, Amey Sonavane, Neeraj Saraf, Sanjiv Saigal, Amit Rastogi, Prashant Bhangui, Srinivasan Thiagrajan, Sanjay K. Yadav, Sujeet Saha, Arvinder S. Soin   +9 more
openaire   +2 more sources

Associations of five obesity indicators with cognitive performance in 30,697 Taiwan Biobank participants

BMC Geriatrics, 2022
Background Obesity adversely influences the central nervous system and cognitive functions. However, the relationship between various obesity indicators and cognitive performance remains controversial.
Wan-Yu Lin
doaj   +1 more source

Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trial

, 2018
Purpose: To evaluate the efficacy and safety of hypofractionated radiotherapy (16 Gy in 2 fractions, 1 week apart) in patients with complicated bone metastases and poor performance status.
Tuan Ha, Edward Chow, Mauricio F. Silva, Bryan Burmeister, Neiro W. da Motta, Felipe P.C. Lisboa, Fabio Trippa, Marko Popovic, Gustavo N. Marta, Guilherme Watte, Ernesto Maranzano   +10 more
core   +2 more sources

Nivolumab for poor performance status patients : retrospective analysis

Annals of Oncology, 2019
Abstract Objective Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcome compared to best supportive care in AGC patients who received at least two prior regimen. Although there is not reliable date of poor performance status(PS) AGC patients who received nivolumab.We investigated efficacy and safety of
Toshihiko Matsumoto, Shogo Kimura, Hitomi Himei, Ukyo Okazaki, Yusuke Kurioka, Takao Tsuduki, Shijiro Takagi, Masahiro Takatani, Takanori Watanabe, Hirofumi Morishita   +9 more
openaire   +1 more source

Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients

Gut and Liver, 2020
Background/Aims: Several clinical factors have been used to predict the response for concurrent chemoradiotherapy (CCRT); however, these factors are insufficient for prognostic predictions. We investigated clinical factors to assess whether they could be
Su Youn Nam, Seong Woo Jeon, Sang Jik Lee, Yong Hwan Kwon, Hyun Seok Lee, Sung Kook Kim   +5 more
doaj   +1 more source

Self-directed home-based neuromuscular electrical stimulation (NMES) in patients with advanced cancer and poor performance status: a feasibility study

, 2020
PurposeConcurrent neuromuscular electrical stimulation (NMES) involving sub-tetanic low frequency and tetanic high frequency which targets aerobic and muscular fitness is a potential alternative to conventional exercise in cancer rehabilitation. However,
O'Connor, Dominic, Caulfield, Brian, Lennon, Olive, Wright, Sarah, O\u27Connor, Dominic   +4 more
core   +2 more sources

The role of chemotherapy in patients with small cell lung cancer and poor performance status [PDF]

Acta Oncologica, 2020
There are limited data on the role of chemotherapy in patients with small cell lung cancer (SCLC) and poor performance status (PS).This was a retrospective analysis of a prospective observational study in patients with SCLC and PS 3 or 4. We recorded the initial therapy, symptom improvement, response rate, overall survival (OS), and the impact of ...
Vanita, Noronha, Rahul, Ravind, Vijay M, Patil, Smruti, Mokal, Amit, Joshi, Nandini, Menon, Akhil, Kapoor, Abhishek, Mahajan, Amit, Janu, Dipti, Nakti, Leena, Shah, Srushti, Shah, Kumar, Prabhash   +12 more
openaire   +2 more sources